Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease [Phase 3]
A Phase 3 trial evaluating efficacy and tolerability of lubiprostone in patients with nonalcoholic fatty liver disease (NAFLD) has been comp…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001) [Phase 2]
Phase 2 clinical trial of efinopegdutide (MK-6024) in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed with r…
-
CLINICAL_TRIALS research · 2023-08-14Clinical Trial Update: The University of Michigan Wellness for Liver Health Study [Phase 1, Phase 2]
Clinical trial update for a University of Michigan study on liver health in nonalcoholic fatty liver disease, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Vitamin E for NASH Treatment in HIV Infected Individuals [Phase 2]
A Phase 2 trial studying vitamin E for treating nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in individuals with HIV wa…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial assessing pharmacodynamics and safety of coadministered DGAT2 inhibitor and ACC inhibitor in participants with presum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]
Phase Ib/II trial evaluating GH509 versus placebo for NASH/NAFLD is ongoing; no results yet from the study.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial investigating the effect of growth hormone on intrahepatic lipid content in patients with nonalcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Fatty Liver Disease in Obese Children [Phase 1, Phase 2]
Phase 1/2 clinical trial update on fatty liver disease in obese children has completed testing under Nemours Children's Clinic.
-
CLINICAL_TRIALS trial_result · 2022-10-13Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]
Phase 2 trial of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis (NASH) and liver cirrhosis has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Guanabenz for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial evaluating how fructose affects metabolism and MRI biomarkers in nonalcoholic fatty liver disease; study terminated with poste…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial update for FM101 in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver [Phase 4]
Phase 4 clinical trial examining the impact of an oral anti-diabetic medication on liver fat in adults with type 2 diabetes and non-alcoholi…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of selonsertib, firsocostat, and cilofexor in adults with nonalcoholic steatohepa…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 study of HTD1801 in adults with nonalcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM) completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial assessing the efficacy and safety of elobixibat in combination with cholestyramine for nonalcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of PXL770 versus placebo in adults with nonalcoholic fatty liver disease (NAFLD). …
-
CLINICAL_TRIALS trial_result · 2021-10-21Clinical Trial Update: Losartan for the Treatment of Pediatric NAFLD [Phase 2]
Phase 2 trial investigating losartan for pediatric nonalcoholic fatty liver disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH [Phase 3]
Phase 3 study update evaluating MSDC-0602K for glycemic control and cardiovascular outcomes in pre-diabetes/Type 2 diabetes with NAFLD/NASH;…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease [Phase 4]
Phase IV trial evaluating statin monotherapy or statin/ezetimibe with respect to hepatic steatosis in patients with hyperlipidemia and nonal…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir [Phase 4]
Phase 4 trial evaluating the effect on liver fat and metabolic parameters when switching a protease inhibitor or efavirenz to raltegravir in…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery [NA]
Clinical trial update studying biomarkers of liver pathology in patients with presumed non-alcoholic steatohepatitis after bariatric surgery…
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]
Phase 2 trial evaluating MET409 alone or with empagliflozin in patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH).